Vaccinex (VCNX) Stock Statistics & Valuation Metrics

Vaccinex has a market cap or net worth of $1.90M. The enterprise value is $1.54M.

Vaccinex has 2,676,637 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vaccinex’s return on equity (ROE) is 7.49 and return on invested capital (ROIC) is 760.66%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Vaccinex had revenue of 601.00K and earned -18.63M in profits. Earnings per share was -8.88.

In the last 12 months, operating cash flow was -16.19M and capital expenditures -22.00K, giving a free cash flow of -16.21M billion.

Vaccinex pays an annual dividend of ―, resulting in a dividend yield of ―

Vaccinex upcoming earnings date is Aug 18, 2025, TBA (Confirmed).

Vaccinex as a current ratio of 0.50, with Debt / Equity ratio of -1.00%

In the past 12 months, Vaccinex has paid 0.00 in taxes.

Vaccinex EV to EBITDA ratio is -0.05, with an EV/FCF ratio of -0.06.

Vaccinex has $1.11M in cash and marketable securities with $25.00K in debt, giving a net cash position of -$1.08M billion.

Gross margin is -547.42%, with operating margin of -3117.30%, and net profit margin of -3100.50%.

The average price target for Vaccinex is $0.50, which is 11.43% higher than the current price. The consensus rating is Hold